Insulet Corp (PODD) Stock Price, Quote & News

Company Profile

Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes in the United States and internationally. The company offers Omnipod platform products comprising Omnipod 5 automated insulin delivery system, which includes a proprietary AID algorithm embedded in the pod that integrates with a third-party continuous glucose monitor to obtain glucose values through wireless Bluetooth communication; Omnipod DASH insulin management system that...

Industry: Medical Devices

Sector: Healthcare

Phone: 978 600 7000

Website: www.insulet.com

Address:

100 Nagog Park, Acton, United States

UNCPETE Aug. 19 at 12:50 AM

$PODD Healthy stock price for a growing, healthy company

0 · Reply

bulltrades1234 Aug. 14 at 6:22 PM

$PODD depressing price action until next earnings

0 · Reply

JInvestTrade Aug. 14 at 1:25 AM

$ABT $DXCM $PODD $SENS $TNDM

1 · Reply

JInvestTrade Aug. 14 at 1:13 AM

$SENS $DXCM $ABT $TNDM $PODD https://lnkd.in/p/gUqQAkEB

0 · Reply

topstockalerts Aug. 11 at 8:39 PM

$PODD this one is quietly making believers

0 · Reply

deepthinker Aug. 11 at 6:34 PM

$MODD So, $TNDM and $PODD are struggling with T2 while. $BBNX is doing well with T2 despite no indication. Why? Same reason as CeQur: simplicity. Here we have Pivot that is a simple device, a T2 targeted device really, and no one wants to own it? Weird.

1 · Reply

Rried332 Aug. 11 at 6:04 PM

$SPY Stocks that are advantageous in my opinion after breaking down technicals and fundamentals using my weighted formula to rank as a value investor: $FIS $NKE $PODD $ZTS

0 · Reply

BriOnH Aug. 11 at 3:54 PM

$SANA $ELDN $DXCM $PODD $TNDM Fellow T1D Investors, this is more of a very exciting PSA to us T1D's than an investing opportunity as Endo Axium is not publicly traded. It is an Australian based company I have been following for a couple years now. They are beginning testing on an oral insulin that is encapsulated in glucose responsive nanoparticles, meaning as blood sugar rises, the nanoparticles release insulin, in humans. I listed their peer review a while back, and they had normoglycemia, meaning no hypos or high bs, in baboons (or maybe gorillas, or something like that I forget off the top of my head). For us T1D's this potentially means just swallowing a pill every 3 days and forgetting we even have T1D! Let's hope it works!!! Even more exciting Sana's SC451 should be entering ph1/2 in the next coming months!!! We have so much good stuff coming!!!!! LFG!!!

4 · Reply

bulltrades1234 Aug. 10 at 2:00 PM

$PODD let’s get to $150

1 · Reply

MarketPulsee Aug. 9 at 10:16 PM

THE WORST-PERFORMING S&P 500 STOCKS THIS YEAR: $TTD -63.7% $CSGP -55.0% $INTU -50.9% $PODD -50.3% $APP -48.5% A stock being down 30–60% doesn’t automatically make it a buy. But it does create a very interesting question: Which companies are facing temporary problems — and which ones have genuinely broken fundamentals? Big drawdowns can create some of the best opportunities when sentiment gets disconnected from long-term business performance. I’m watching the names where valuation, fundamentals, and future growth could start aligning again. Which one would you consider buying after this selloff? Follow my profile for more contrarian ideas, market opportunities, and high-conviction setups before they become obvious. NFA. DYOR.

1 · Reply

Contact Robbins LLP for Information About Leading the Lawsuit That Alleges Insulet Corporation Misled Investors Regarding the Safety and Reliability of its Insulin Delivery Products

Aug 12, 2026, 8:00 PM EDT - 6 days ago

Insulet Corporation Investors With Significant Losses Must Act By August 31, 2026

Aug 11, 2026, 10:06 AM EDT - 7 days ago

SueWallSt Reminds Shareholders of a Lead Plaintiff Deadline of August 31, 2026 in Insulet Corporation Lawsuit - PODD

Aug 5, 2026, 12:17 PM EDT - 13 days ago

This Medtech Beat Earnings Estimates. It's the Worst S&P 500 Stock Today.

Aug 5, 2026, 9:00 AM EDT - 13 days ago

Insulet Slides: Investor presentation

Aug 5, 2026, 8:11 AM EDT - 14 days ago

Insulet cuts sales growth forecast on slower US insulin-pump sales; shares fall

Aug 5, 2026, 8:00 AM EDT - 14 days ago

Insulet Earnings Call Transcript: Q2 2026

Aug 5, 2026, 8:00 AM EDT - 14 days ago

Insulet Earnings release: Q2 2026

Aug 5, 2026, 8:00 AM EDT - 14 days ago

Insulet Slides: Q2 2026

Aug 5, 2026, 8:00 AM EDT - 14 days ago

Insulet Quarterly report: Q2 2026

Aug 5, 2026, 7:00 AM EDT - 14 days ago

Insulet Reports Second Quarter 2026 Results

Aug 4, 2026, 7:00 PM EDT - 14 days ago

PODD INVESTOR REMINDER: Insulet Corporation Investors Have Until August 31, 2026 To Seek Lead Plaintiff Role

Jul 24, 2026, 6:36 AM EDT - 26 days ago

$PODD Fraud Notification: Insulet Sued for Fraud Over Misrepresentations about its Safety Issues – Investors Notified to Contact BFA Law

Jul 14, 2026, 3:00 AM EDT - 5 weeks ago

Insulet Partners with Calm to Bring Mindfulness and Well-Being Tools to the Diabetes Community, Featuring a New Sleep Story Narrated by Lila Moss

Jul 13, 2026, 5:14 PM EDT - 5 weeks ago

PODD Investors Have Rights - If You Lost Money Investing in Insulet Corporation Contact Robbins LLP for Information About Recovering Your Losses

Jul 6, 2026, 12:04 PM EDT - 6 weeks ago

INSULET CORPORATION (PODD) INVESTOR ALERT Investors With Large Losses in Insulet Corporation Should Contact Bernstein Liebhard LLP To Discuss Their Rights

Jul 6, 2026, 7:00 AM EDT - 6 weeks ago

Insulet Slides: Investor presentation

Jul 3, 2026, 1:31 PM EDT - 6 weeks ago

Grabar Law Office Investigates Claims on Behalf of Shareholders of Insulet Corporation (PODD)

Jul 1, 2026, 7:00 AM EDT - 7 weeks ago

Insulet to Announce Second Quarter 2026 Financial Results on August 5, 2026

Jun 30, 2026, 7:55 AM EDT - 7 weeks ago

20 stocks in the S&P 500 that plunged the most in 2026's first half

ACN ADBE BR BSX CRM CSGP CTSH

Jun 25, 2026, 7:00 AM EDT - 7 weeks ago

Insulet Announces Appointment of Jonathan J. Mazelsky to its Board of Directors

Jun 4, 2026, 7:00 AM EDT - 2 months ago

Insulet to Spotlight New Data and Innovations Demonstrating How Omnipod® Simplifies Diabetes Management and Delivers Strong Clinical Outcomes at the American Diabetes Association 86th Scientific Sessions

Jun 3, 2026, 3:00 PM EDT - 2 months ago

Insulet Transcript: 46th Annual William Blair Growth Stock Conference

Jun 3, 2026, 3:00 PM EDT - 2 months ago

Insulet Slides: 46th Annual William Blair Growth Stock Conference

Jun 3, 2026, 7:00 AM EDT - 2 months ago

Insulet Announces U.S. Rollout of Enhanced Omnipod® 5 Algorithm and Expands Compatibility with Abbott's FreeStyle Libre 3 Plus Sensor

May 28, 2026, 10:34 AM EDT - 2 months ago

US court overturns Insulet's $452 mln insulin-pump trade secret verdict against EOFlow

May 27, 2026, 4:05 PM EDT - 2 months ago

Insulet to Participate in William Blair 46th Annual Growth Stock Conference

May 26, 2026, 4:50 PM EDT - 3 months ago

Insulet flags dosing defect in some Omnipod devices, sees up to $50 million cost

May 26, 2026, 4:05 PM EDT - 3 months ago

Insulet Initiates Voluntary Medical Device Correction for Certain Omnipod® Pods in the U.S. and Affected International Markets

May 20, 2026, 10:05 AM EDT - 3 months ago

These 15 S&P 500 stocks could be contrarian ways to play the market's uneven rally

APH APP AXON CSGP CVNA EL FICO

May 20, 2026, 8:00 AM EDT - 3 months ago

Insulet Transcript: AGM 2026

May 13, 2026, 12:20 PM EDT - 3 months ago

Insulet Transcript: Bank of America Global Healthcare Conference 2026

May 13, 2026, 12:20 PM EDT - 3 months ago

Insulet Slides: FY 2026

May 6, 2026, 8:00 AM EDT - 3 months ago

Insulet Earnings Call Transcript: Q1 2026

May 6, 2026, 8:00 AM EDT - 3 months ago

Insulet Earnings release: Q1 2026

May 6, 2026, 8:00 AM EDT - 3 months ago

Insulet Slides: Q1 2026

May 6, 2026, 8:00 AM EDT - 3 months ago

Insulet Quarterly report: Q1 2026

May 6, 2026, 7:46 AM EDT - 3 months ago

Insulet lifts annual revenue forecast after quarterly beat on strong insulin pump demand

May 6, 2026, 7:00 AM EDT - 3 months ago

Insulet Reports First Quarter 2026 Results

May 6, 2026, 7:00 AM EDT - 3 months ago

Insulet Slides: Investor presentation

May 5, 2026, 7:00 AM EDT - 3 months ago

Insulet Unveils 2025 Sustainability Report Highlighting Strong Momentum Across Key Priorities

May 5, 2026, 7:00 AM EDT - 3 months ago

Insulet Slides: Omnipod® 5 competitive clinical performance presentation

May 4, 2026, 7:00 AM EDT - 3 months ago

Insulet Initiates EVOLVE Pivotal Study to Advance Fully Closed-Loop Automated Insulin Delivery System for Type 2 Diabetes

Apr 28, 2026, 7:00 AM EDT - 4 months ago

Insulet to Participate in BofA Securities 2026 Health Care Conference

Apr 6, 2026, 8:00 AM EDT - 4 months ago

Insulet Proxy statement: Proxy filing

Apr 6, 2026, 8:00 AM EDT - 4 months ago

Insulet Proxy statement: Proxy filing

Apr 1, 2026, 7:00 AM EDT - 5 months ago

Insulet to Announce First Quarter 2026 Financial Results on May 6, 2026

Mar 30, 2026, 8:30 AM EDT - 5 months ago

Insulet Appoints Mike Panos as Chief Commercial Officer

Mar 12, 2026, 5:22 PM EDT - 5 months ago

Insulet recalls some insulin devices in US over leakage risk

Mar 12, 2026, 4:05 PM EDT - 5 months ago

Insulet Initiates Voluntary Medical Device Correction for Certain Omnipod® 5 Pods in the U.S.

Mar 11, 2026, 4:01 PM EDT - 5 months ago

Insulet Presents Promising Study Results for Fully Closed-Loop Automated Insulin Delivery System for Adults with Type 2 Diabetes

Mar 10, 2026, 7:00 AM EDT - 5 months ago

Insulet to Present EVOLUTION 2 Results on Omnipod® Fully Closed-Loop System for Adults with Type 2 Diabetes at International Conference on Advanced Technologies & Treatments for Diabetes (ATTD)

Feb 18, 2026, 8:00 AM EST - 6 months ago

Insulet Earnings Call Transcript: Q4 2025

Feb 18, 2026, 8:00 AM EST - 6 months ago

Insulet Annual report: Q4 2025

Feb 18, 2026, 8:00 AM EST - 6 months ago

Insulet Earnings release: Q4 2025

Feb 18, 2026, 8:00 AM EST - 6 months ago

Insulet Slides: Q4 2025

Feb 18, 2026, 7:55 AM EST - 6 months ago

Insulet beats quarterly estimates on strong demand for wearable insulin pumps

Feb 18, 2026, 7:00 AM EST - 6 months ago

Insulet Reports Fourth Quarter and Full Year 2025 Results

Feb 18, 2026, 7:00 AM EST - 6 months ago

Insulet Slides: Investor presentation

Feb 5, 2026, 7:00 AM EST - 6 months ago

Insulet Launches Omnipod® 5 and Omnipod Discover™ in the Middle East to Transform Diabetes Care

Jan 19, 2026, 12:41 PM EST - 7 months ago

Is PODD A Better Bet Than ISRG Stock?

ISRG

Jan 13, 2026, 2:15 PM EST - 7 months ago

Insulet Transcript: 44th Annual J.P. Morgan Healthcare Conference

Jan 13, 2026, 2:15 PM EST - 7 months ago

Insulet Slides: 44th Annual J.P. Morgan Healthcare Conference

Jan 9, 2026, 6:00 AM EST - 7 months ago

Insulet to Announce Fourth Quarter and Full Year 2025 Financial Results on February 18, 2026

UNCPETE Aug. 19 at 12:50 AM

$PODD Healthy stock price for a growing, healthy company

0 · Reply

bulltrades1234 Aug. 14 at 6:22 PM

$PODD depressing price action until next earnings

0 · Reply

JInvestTrade Aug. 14 at 1:25 AM

$ABT $DXCM $PODD $SENS $TNDM

1 · Reply

JInvestTrade Aug. 14 at 1:13 AM

$SENS $DXCM $ABT $TNDM $PODD https://lnkd.in/p/gUqQAkEB

0 · Reply

topstockalerts Aug. 11 at 8:39 PM

$PODD this one is quietly making believers

0 · Reply

deepthinker Aug. 11 at 6:34 PM

1 · Reply

Rried332 Aug. 11 at 6:04 PM

$SPY Stocks that are advantageous in my opinion after breaking down technicals and fundamentals using my weighted formula to rank as a value investor: $FIS $NKE $PODD $ZTS

0 · Reply

BriOnH Aug. 11 at 3:54 PM

4 · Reply

bulltrades1234 Aug. 10 at 2:00 PM

$PODD let’s get to $150

1 · Reply

MarketPulsee Aug. 9 at 10:16 PM

1 · Reply

crabbypatty31 Aug. 9 at 3:26 PM

$PODD Started a small position here on Thursday. Last time I bought this I got stopped out at $165 and the next time I looked it was about double that 😬 Sometimes stop losses are great and other times...

1 · Reply

EquityVoyager_1 Aug. 8 at 8:23 PM

S&P 500’S BIGGEST LOSERS THIS YEAR - THIS LIST HURTS These are among the hardest-hit S&P 500 names so far this year: $TTD → -63.7% $CSGP → -55.0% $INTU → -50.9% $PODD → -50.3% $APP → -48.5% Massive drawdowns can create opportunity - but they can also signal deeper problems. Which beaten-down name deserves a comeback? Are you going to miss out again? Another alert is coming soon. If notifications are off, chances are you’ll only notice the move once it’s already in progress.

1 · Reply

WallStKoal Aug. 8 at 8:04 PM

Capitulation Watch: Healthcare Tech & Financial Infrastructure $PODD | YTD -50.3% | Insulin delivery tech leader $BSX | YTD -48.3% | Cardiovascular device giant $ISRG | YTD -33.1% | Robotic surgery platform $FICO | YTD -38.4% | Credit scoring monopoly $COIN | YTD -32.1% | Crypto infrastructure anchor Accumulating dislocated quality requires patience and system. Next execution alert coming soon. Head to my profile to see my full log.

0 · Reply

EquityBlueprint Aug. 8 at 7:52 PM

Capitulation Watch: Healthcare Tech & Financial Infrastructure $PODD | YTD -50.3% | Insulin delivery tech leader $BSX | YTD -48.3% | Cardiovascular device giant $ISRG | YTD -33.1% | Robotic surgery platform $FICO | YTD -38.4% | Credit scoring monopoly $COIN | YTD -32.1% | Crypto infrastructure anchor FIS | YTD -35.7% | Core banking IT infrastructure Accumulating dislocated quality requires patience and system. The next major alert is coming soon. Head to my profile for full updates

0 · Reply

Stocktwits52wLows Aug. 7 at 3:16 PM

$PODD printed a new 52-week low today

0 · Reply

bulltrades1234 Aug. 7 at 1:43 PM

$PODD hold or sell thoughts

3 · Reply

Knot2 Aug. 7 at 1:05 AM

$PODD sell puts?

0 · Reply

Butters33 Aug. 6 at 10:15 PM

$PODD - I am a type 1 diabetic who utilizes the Omnipod. I trust PODD with my life so I may as well trust them as an investor. I’m sure many customers are like me who plan to stay on the Omnipod for many years to come. I have been using an insulin pump since the initial pump was invented and no other pump has made such an improvement to my life as the Omnipod. PODD should make it a closed end system by incorporating a CGM on the pump itself. Just my opinion!!

0 · Reply

mexmanTV Aug. 6 at 9:41 PM

$PODD

0 · Reply

NorthstarT1D Aug. 6 at 2:06 PM

$PODD these analysts are laughable. They lowered 2026 guidance by 1%, analysts are cutting targets by 30-50%

1 · Reply

anachartanalyst Aug. 6 at 12:02 PM

$PODD https://anachart.com/wp-content/uploads/2026/08/1786017722_soc-img.jpg

0 · Reply

anachartanalyst Aug. 6 at 11:02 AM

$PODD https://anachart.com/wp-content/uploads/2026/08/1786014138_soc-img.jpg

0 · Reply

Market Cap	9.69B
Revenue (ttm)	2.71B
Net Income (ttm)	247.10M
EPS (ttm)	N/A
PE Ratio	24.42
Forward PE	22.01
Profit Margin	9.12%
Debt to Equity Ratio	0.67

Volume	1,622,300
Avg Vol	1,595,852
Day's Range	N/A - N/A
Shares Out	69.35M
Stochastic %K	93%
Beta	1.10
Analysts	Sell
Price Target	$172.46